Reducing Transcranial Direct Current Stimulation-Induced Erythema With Skin Pretreatment: Considerations for Sham-Controlled Clinical Trials

Neuromodulation

Volumn 18, Issue 4, 2015, Pages 261-265

  Guarienti, Fabiana ^a,b   Caumo, Wolnei ^b   Shiozawa, Pedro ^a,c   Cordeiro, Quirino ^c   Boggio, Paulo S ^d   Benseñor, Isabela M ^a   Lotufo, Paulo A ^a   Bikson, Marom ^e   Brunoni, André R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^d MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

^e CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Blinding integrity; erythema; ketoprofen; sham controlled design; skin reddening; transcranial direct current stimulation

Indexed keywords

HYDROXYZINE; KETOPROFEN; LIDOCAINE; PLACEBO; ANTIPRURITIC AGENT; LOCAL ANESTHETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ADVERSE OUTCOME; ARTICLE; BURNING SENSATION; CONTROLLED STUDY; ERYTHEMA; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; QUESTIONNAIRE; SCORING SYSTEM; SKIN COLOR; SKIN PAIN; SKIN PRURITUS; SKIN TINGLING; SOMNOLENCE; TRANSCRANIAL DIRECT CURRENT STIMULATION; ADVERSE EFFECTS; INTRADERMAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TIME; YOUNG ADULT;

ADMINISTRATION, CUTANEOUS; ADULT; ANESTHETICS, LOCAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPRURITICS; ERYTHEMA; FEMALE; HEALTHY VOLUNTEERS; HUMANS; HYDROXYZINE; KETOPROFEN; LIDOCAINE; MALE; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TRANSCRANIAL DIRECT CURRENT STIMULATION; YOUNG ADULT;

EID: 84930240805     PISSN: 10947159     EISSN: 15251403     Source Type: Journal    
DOI: 10.1111/ner.12230     Document Type: Article

References (21)

1. Brunoni AR, Schestatsky P, Lotufo PA, Bensenor IM, Fregni F,. Comparison of blinding effectiveness between sham tDCS and placebo sertraline in a 6-week major depression randomized clinical trial. Clin Neurophysiol 2014; 125: 298-305.
2. O'Connell NE, Cossar J, Marston L, et al. Rethinking clinical trials of transcranial direct current stimulation: participant and assessor blinding is inadequate at intensities of 2 mA. PLoS ONE 2012; 7: e47514.
3. Palm U, Reisinger E, Keeser D, et al. Evaluation of sham transcranial direct current stimulation for randomized, placebo-controlled clinical trials. Brain Stimul 2013; 6: 690-695.
4. Brunoni AR, Ferrucci R, Fregni F, Boggio PS, Priori A,. Transcranial direct current stimulation for the treatment of major depressive disorder: a summary of preclinical, clinical and translational findings. Prog Neuropsychopharmacol Biol Psychiatry 2012; 39: 9-16.
5. Ferrucci R, Bortolomasi M, Brunoni AR, et al. Comparative benefits of transcranial direct current stimulation (tDCS) treatment in patients with mild/moderate vs. severe depression. Clin Neuropsychiatry 2009; 6: 246-251.
6. Dundas JE, Thickbroom GW, Mastaglia FL,. Perception of comfort during transcranial DC stimulation: effect of NaCl solution concentration applied to sponge electrodes. Clin Neurophysiol 2007; 118: 1166-1170.
7. Brunoni AR, Amadera J, Berbel B, et al. A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. Int J Neuropsychopharmacol 2011; 14: 1133-1145.
8. Cohen J,. Statistical power analysis for the behavioral sciences. New Jersey: Lawrence Erlbaum Associates, 1988.
9. Tartas M, Bouye P, Koitka A, et al. Cathodal current-induced vasodilation to single application and the amplified response to repeated application in humans rely on aspirin-sensitive mechanisms. J Appl Physiol 2005; 99: 1538-1544.
10. Brenner M, Hearing VJ,. The protective role of melanin against UV damage in human skin. Photochem Photobiol 2008; 84: 539-549.
11. Wang H, Papoiu AD, Coghill RC, et al. Ethnic differences in pain, itch and thermal detection in response to topical capsaicin: African Americans display a notably limited hyperalgesia and neurogenic inflammation. Br J Dermatol 2010; 162: 1023-1029.
12. McFadden JL, Borckardt JJ, George MS, Beam W,. Reducing procedural pain and discomfort associated with transcranial direct current stimulation. Brain Stimul 2011; 4: 38-42.
13. Loffler H, Kampf G, Schmermund D, Maibach HI,. How irritant is alcohol? Br J Dermatol 2007; 157: 74-81.
14. Villamar MF, Volz MS, Bikson M, et al. Technique and considerations in the use of 4 × 1 ring high-definition transcranial direct current stimulation (HD-tDCS). J Vis Exp 2013; 77: e50309.
15. Plow EB, Obretenova SN, Halko MA, et al. Combining visual rehabilitative training and noninvasive brain stimulation to enhance visual function in patients with hemianopia: a comparative case study. PM & R 2011; 3: 825-835.
16. Bolognini N, Vallar G, Casati C, et al. Neurophysiological and behavioral effects of tDCS combined with constraint-induced movement therapy in poststroke patients. Neurorehabil Neural Repair 2011; 25: 819-829.
17. Liebetanz D, Koch R, Mayenfels S, et al. Safety limits of cathodal transcranial direct current stimulation in rats. Clin Neurophysiol 2009; 120: 1161-1167.
18. Nitsche MA, Cohen LG, Wassermann EM, et al. Transcranial direct current stimulation: state of the art 2008. Brain Stimul 2008; 1: 206-223.
19. Brunoni AR, Nitsche MA, Bolognini N, et al. Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions. Brain Stimul 2012; 5: 175-195.
20. DaSilva AF, Volz MS, Bikson M, Fregni F,. Electrode positioning and montage in transcranial direct current stimulation. J Vis Exp 2011;pii: 2744.
21. Kumar MG, Lin S,. Transdermal iontophoresis: impact on skin integrity as evaluated by various methods. Crit Rev Ther Drug Carrier Syst 2008; 25: 381-401.